visilizumab tentative trade name nuvion pdl biopharma inc humanized monoclonal antibody investigated use immunosuppressive drug patients ulcerative colitis crohns disease visilizumab binds receptor certain activated cells without affecting resting cells currently clinical studies treatment ulcerative colitis crohns pdl biopharma inc canceled production visilizumab following phase iiiii clinical trials citing inefficacy poor safety profile compared drugs market major nevertheless clinical trials continue various diseases like multiple diabetes mellitus type july visilizumab also radiolabelled imaging immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikivisilizumab